News | July 29, 2007

FDA Approves Swab Skin Antiseptic for Inclusion in Kits

July 30, 2007 - PDI recently announced the FDA approval of Chlorascrub Swab, the first 3.15 percent Chlorhexidine Gluconate (w/v) and 70 percent Isopropyl Alcohol (v/v) pre-injection skin antiseptic for inclusion in kits.

PDI, the Healthcare Division of Nice-Pak Products, Inc., has now made its Chlorascrub Swab available to kit manufacturers.

The Chlorascrub Swab packaging has been specifically designed to withstand the Ethylene Oxide (EtO) sterilization process for the manufacture of finished sterile kits. PDI will also continue to market its current FDA-approved non-kit Chlorascrub Swab product.

For more information: